表紙:先進視覚化技術の世界市場予測(~2028年):コンポーネント、画像モダリティ、臨床応用、地域別の分析
市場調査レポート
商品コード
1094368

先進視覚化技術の世界市場予測(~2028年):コンポーネント、画像モダリティ、臨床応用、地域別の分析

Advanced Visualization Market Forecasts to 2028 - Global Analysis By Component, Imaging Modality (Computed Tomography, Ultrasound, Nuclear Medicine, Radiotherapy, Endoscopy), Clinical Application, and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
先進視覚化技術の世界市場予測(~2028年):コンポーネント、画像モダリティ、臨床応用、地域別の分析
出版日: 2022年06月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の先進視覚化技術の市場規模は、2021年に25億5,000万米ドルとなり、予測期間中に13.2%のCAGRで拡大し、2028年までに60億8,000万米ドルに達すると予測されています。

当レポートでは世界の先進視覚化技術市場を調査し、市場の促進要因・抑制要因、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の先進視覚化技術市場:ソリューションタイプ別

  • スタンドアロンワークステーションベースのソリューション
  • エンタープライズワイドシンクライアントベースのソリューション

第6章 世界の先進視覚化技術市場:コンポーネント別

  • ハードウェアとソフトウェア
  • サービス
    • 販売後および保守サービス
    • トレーニングおよび教育サービス
    • 実装サービス
    • コンサルティング/最適化サービス

第7章 世界の先進視覚化技術市場:画像モダリティ別

  • コンピュータ断層撮影(CT)
  • 陽電子放出断層撮影(PET)
  • 磁気共鳴画像法(MRI)
  • 超音波
  • 核医学
  • 放射線療法(RT)
  • 単一光子放射型コンピューター断層撮影(SPECT)
  • 内視鏡検査
  • X線および透視検査

第8章 世界の先進視覚化技術市場:臨床応用別

  • 心臓病
  • 腫瘍
  • 神経
  • 放射線/インターベンショナルラジオロジー
  • 心血管
  • 整形外科
  • 胃腸病および泌尿器

第9章 世界の先進視覚化技術市場:エンドユーザー別

  • 画像センター/診断センター
  • 病院、外科センター
  • 学術調査センター

第10章 世界の先進視覚化技術市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東・アフリカ

第11章 主な発展

  • 契約、パートナーシップ、コラボレーション、ジョイントベンチャー
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の重要な戦略

第12章 企業プロファイル

  • General Electric Company
  • Toshiba Corporation
  • Siemens AG
  • Koninklijke Philips N.V.
  • Canon Inc
  • Vital Images Inc.
  • Thermo Fisher Scientific
  • Fujifilm Holdings Corporation
  • Terarecon, Inc.
  • Olympus Corporation
  • Qi Imaging LLC
  • Pro Medicus Limited
  • AGFA Gevaert N.V
  • Visage Imaging, Inc.
  • Carestream Health, Inc.
  • Analogic Corporation
  • BenQ Medical Technology
図表

List of Tables

  • Table 1 Global Advanced Visualization Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Advanced Visualization Market Outlook, By Solution Type (2020-2028) ($MN)
  • Table 3 Global Advanced Visualization Market Outlook, By Standalone Workstation-Based Solutions (2020-2028) ($MN)
  • Table 4 Global Advanced Visualization Market Outlook, By Enterprise-Wide Thin Client-Based Solutions (2020-2028) ($MN)
  • Table 5 Global Advanced Visualization Market Outlook, By Component (2020-2028) ($MN)
  • Table 6 Global Advanced Visualization Market Outlook, By Hardware & Software (2020-2028) ($MN)
  • Table 7 Global Advanced Visualization Market Outlook, By Services (2020-2028) ($MN)
  • Table 8 Global Advanced Visualization Market Outlook, By Post-Sale and Maintenance Services (2020-2028) ($MN)
  • Table 9 Global Advanced Visualization Market Outlook, By Training and Education Services (2020-2028) ($MN)
  • Table 10 Global Advanced Visualization Market Outlook, By Implementation Services (2020-2028) ($MN)
  • Table 11 Global Advanced Visualization Market Outlook, By Consulting/Optimization Services (2020-2028) ($MN)
  • Table 12 Global Advanced Visualization Market Outlook, By Imaging Modality (2020-2028) ($MN)
  • Table 13 Global Advanced Visualization Market Outlook, By Computed Tomography (CT) (2020-2028) ($MN)
  • Table 14 Global Advanced Visualization Market Outlook, By Positron Emission Tomography (PET) (2020-2028) ($MN)
  • Table 15 Global Advanced Visualization Market Outlook, By Magnetic Resonance Imaging (MRI) (2020-2028) ($MN)
  • Table 16 Global Advanced Visualization Market Outlook, By Ultrasound (2020-2028) ($MN)
  • Table 17 Global Advanced Visualization Market Outlook, By Nuclear Medicine (2020-2028) ($MN)
  • Table 18 Global Advanced Visualization Market Outlook, By Radiotherapy (RT) (2020-2028) ($MN)
  • Table 19 Global Advanced Visualization Market Outlook, By Single-Photon Emission Computerized Tomography (SPECT) (2020-2028) ($MN)
  • Table 20 Global Advanced Visualization Market Outlook, By Endoscopy (2020-2028) ($MN)
  • Table 21 Global Advanced Visualization Market Outlook, By X-Ray and Fluoroscopy (2020-2028) ($MN)
  • Table 22 Global Advanced Visualization Market Outlook, By Clinical Application (2020-2028) ($MN)
  • Table 23 Global Advanced Visualization Market Outlook, By Cardiology (2020-2028) ($MN)
  • Table 24 Global Advanced Visualization Market Outlook, By Oncology (2020-2028) ($MN)
  • Table 25 Global Advanced Visualization Market Outlook, By Neurology (2020-2028) ($MN)
  • Table 26 Global Advanced Visualization Market Outlook, By Radiology/Interventional Radiology (2020-2028) ($MN)
  • Table 27 Global Advanced Visualization Market Outlook, By Cardiovascular (2020-2028) ($MN)
  • Table 28 Global Advanced Visualization Market Outlook, By Orthopedics (2020-2028) ($MN)
  • Table 29 Global Advanced Visualization Market Outlook, By Gastroenterology and Urology (2020-2028) ($MN)
  • Table 30 Global Advanced Visualization Market Outlook, By End User (2020-2028) ($MN)
  • Table 31 Global Advanced Visualization Market Outlook, By Imaging Centers/Diagnostic Centers (2020-2028) ($MN)
  • Table 32 Global Advanced Visualization Market Outlook, By Hospitals, and Surgical Centers (2020-2028) ($MN)
  • Table 33 Global Advanced Visualization Market Outlook, By Academic and Research Centers (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次
Product Code: SMRC21536

According to Stratistics MRC, the Global Advanced Visualization Market is accounted for $2.55 billion in 2021 and is expected to reach $6.08 billion by 2028 growing at a CAGR of 13.2% during the forecast period. Advanced visualization mainly comprises medical equipment that is equipped with advanced software technology that efficiently displays many aspects of living cells which results in an enhanced diagnosis of the diseases. It is a new generation technology that uses business intelligence (BI) tool allowing the users to visualize an enhanced image quality. It is mainly helpful for healthcare specialists as it allows a better understanding of clinical issues, in turn, resulting in high-quality healthcare facilities while dropping the costs. Advanced visualization is a contemporary diagnostic method that provides a visualization platform to the consumer which essentially results in providing enhanced imaging and functionalities in the imaging technique.

Market Dynamics:

Driver:

Increasing demand for advance visualization technology by enterprises

In the past few years, the quantity of data generated through various technologies such as the internet of things (IoT) and other data sources is rising exponentially. This huge data pool comprises both unstructured and structured data. Companies are preferring business intelligence software with advanced technologies such as artificial intelligence (AI) to handle huge amounts of data and generate a better and knowledgeable interpretation of statistics. For instance, in September 2019, Deloitte Touche Tohmatsu Ltd., one of the major players in the advisory services sector launched an advanced public data visualization tool which provides insights based on coding algorithms, visualization techniques and refines the same with artificial intelligence (AI), machine learning (ML), blockchain and big data analytics among others. The integration of such advanced technologies is supplementing the market growth.

Restraint:

High diagnostics cost

The high costs of diagnostics using advanced visualization systems are expected to limit demand generation. The high prices charged by hospitals are primarily owing to their high investments to buy healthcare scanners and advanced visualization systems. In developing economies, the diagnostic costs are considerably lower. Though, this increases the time required by hospitals to break even on the high investments, which dissuades them from investing in advanced imaging technologies. For instance, the cost of a single MRI scan can vary from $400 to $10,500 in the US depending on the region, hospital, and scan that doctor runs. On average, a brain MRI costs between $1600 and $8400.

Opportunity:

Growing investments in visualization platforms and company collaborations to aid in expansion

Considering the upcoming opportunities allied with statistics and its depiction, numerous companies are investing in enhancing their analytics and visualization capabilities with unremitting investments in research and development (R&D). Moreover, companies are also focusing on acquiring advanced visualization platform vendors to widen their portfolio and reinforce their analytics and business, intelligence division. The rising investments in the field of advanced visualization and major acquisitions of the companies are anticipated to contribute to the growth of the market in the coming years.

Threat:

Limited availability of reimbursements for radiology-based diagnostic procedures

Reimbursement changes for the technical part of imaging procedures (such as MRI and CT scans) is the most critical radiology billing problem. Several departments such as radiology, interventional radiology, and radiation oncology witnessed payment changes since 2015. Moreover, there was a decrease in the payment rate for many kinds of imaging procedures for radiologists, and this may impact finances in radiology departments. Thus, reimbursement cuts for radiology may hamper the demand for advanced visualization software as radiology accounts for a major share of 54% in 2015.

The hardware & software segment is expected to be the largest during the forecast period

The hardware & software segment is estimated to have a lucrative growth, due to the expansion of technologically advanced software, increasing focus of healthcare organizations to streamline, and upsurge workflow competence. The introduction of technically sophisticated software has aided the segment growth. Also, the AV systems are more prevalent in hospitals and diagnostic centers to streamline and improve workflow efficiency and the ease with which they may be integrated into PACS.

The oncology segment is expected to have the highest CAGR during the forecast period

The oncology segment is anticipated to witness the fastest CAGR growth during the forecast period, owing to rising technological advancements, increase in the number of global cancer patients, rising prevalence of various types of cancer, and increase in the espousal of the advanced visualization tools in healthcare facilitites. Advanced visualization assists medical professionals to accurately diagnose cancerous growths and help decide the appropriate course of treatment. For instance, the 4D image reconstruction provided by advanced visualization software shows the true shape of the anatomical objects in motion. It identifies the dynamic range of motion to assist in the radiotherapy treatment plan process.

Region with highest share:

North America is projected to hold the largest market share during the forecast period, owing to faster adoption of novel diagnostic imaging technologies, increasing cases of chronic diseases and presence of better healthcare infrastructure, rise in capital income in developed and developing countries, higher preference for advanced visualization solutions for diagnostic imaging, and large number of disease diagnostic procedures. On the other hand, the Canadian market is anticipated to record a promising share and contributed to the North American market growth, due to strong R&D infrastructure in Canada, commercialization of sophisticated diagnostic tools, and a high prevalence of target illnesses, are all factors likely to trigger the region's need for enhanced visualization products.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period owing to increased disposable income, rising market penetration of advanced diagnostic technologies, public healthcare funding growth in emerging economies like China and India, and rising public awareness related to benefits of advanced diagnostic techniques in effective disease management. The market players in the region are China, Japan, and India. The Indian advanced visualization market is anticipated to witness a promising share in the APAC market during the forecast period, due to the increasing prevalence of chronic disease, improving healthcare infrastructure, and supportive government policies.

Key players in the market

Some of the key players profiled in the Advanced Visualization Market include General Electric Company, Toshiba Corporation, Siemens AG, Koninklijke Philips N.V., Canon Inc, Vital Images Inc., Thermo Fisher Scientific, Fujifilm Holdings Corporation, Terarecon, Inc., Olympus Corporation, Qi Imaging LLC, Pro Medicus Limited, AGFA Gevaert N.V, Visage Imaging, Inc., Carestream Health, Inc., Analogic Corporation, and BenQ Medical Technology.

Key Developments:

In June, 2021, Toshiba Corporation launched an updated version of its MPF platform e-BRIDGE Next. These features are designed to help organizations' overall efficiency along with an increase in their security.

In October 2020, General Electric announced that its Ultra Edition package on Vivid1 cardiovascular ultrasound systems received US FDA 510k clearance. The system includes new Artificial Intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

In February 2019, Philips announced the launch of IntelliSpace Portal 11 advanced visualization and quantification software. This new version further extends the clinical innovation of the Portal, with enhancements to improve workflow efficiencies, bridging secure data sharing between systems within the hospital network to address the security and privacy needs of customers globally.

Solution Types Covered:

  • Standalone Workstation-Based Solutions
  • Enterprise-Wide Thin Client-Based Solutions

Components Covered:

  • Hardware & Software
  • Services

Imaging Modalities Covered:

  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Nuclear Medicine
  • Radiotherapy (RT)
  • Single-Photon Emission Computerized Tomography (SPECT)
  • Endoscopy
  • X-Ray and Fluoroscopy

Clinical Applications Covered:

  • Cardiology
  • Oncology
  • Neurology
  • Radiology/Interventional Radiology
  • Cardiovascular
  • Orthopedics
  • Gastroenterology and Urology

End Users Covered:

  • Imaging Centers/Diagnostic Centers
  • Hospitals, and Surgical Centers
  • Academic and Research Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Advanced Visualization Market, By Solution Type

  • 5.1 Introduction
  • 5.2 Standalone Workstation-Based Solutions
  • 5.3 Enterprise-Wide Thin Client-Based Solutions

6 Global Advanced Visualization Market, By Component

  • 6.1 Introduction
  • 6.2 Hardware & Software
  • 6.3 Services
    • 6.3.1 Post-Sale and Maintenance Services
    • 6.3.2 Training and Education Services
    • 6.3.3 Implementation Services
    • 6.3.4 Consulting/Optimization Services

7 Global Advanced Visualization Market, By Imaging Modality

  • 7.1 Introduction
  • 7.2 Computed Tomography (CT)
  • 7.3 Positron Emission Tomography (PET)
  • 7.4 Magnetic Resonance Imaging (MRI)
  • 7.5 Ultrasound
  • 7.6 Nuclear Medicine
  • 7.7 Radiotherapy (RT)
  • 7.8 Single-Photon Emission Computerized Tomography (SPECT)
  • 7.9 Endoscopy
  • 7.10 X-Ray and Fluoroscopy

8 Global Advanced Visualization Market, By Clinical Application

  • 8.1 Introduction
  • 8.2 Cardiology
  • 8.3 Oncology
  • 8.4 Neurology
  • 8.5 Radiology/Interventional Radiology
  • 8.6 Cardiovascular
  • 8.7 Orthopedics
  • 8.8 Gastroenterology and Urology

9 Global Advanced Visualization Market, By End User

  • 9.1 Introduction
  • 9.2 Imaging Centers/Diagnostic Centers
  • 9.3 Hospitals, and Surgical Centers
  • 9.4 Academic and Research Centers

10 Global Advanced Visualization Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 General Electric Company
  • 12.2 Toshiba Corporation
  • 12.3 Siemens AG
  • 12.4 Koninklijke Philips N.V.
  • 12.5 Canon Inc
  • 12.6 Vital Images Inc.
  • 12.7 Thermo Fisher Scientific
  • 12.8 Fujifilm Holdings Corporation
  • 12.9 Terarecon, Inc.
  • 12.10 Olympus Corporation
  • 12.11 Qi Imaging LLC
  • 12.12 Pro Medicus Limited
  • 12.13 AGFA Gevaert N.V
  • 12.14 Visage Imaging, Inc.
  • 12.15 Carestream Health, Inc.
  • 12.16 Analogic Corporation
  • 12.17 BenQ Medical Technology